Modeling error in experimental assays using the bootstrap principle: Understanding discrepancies between assays using different dispensing technologies
Abstract
All experimental assay data contains error, but the magnitude, type, and primary origin of this error is often not obvious. Here, we describe a simple set of assay modeling techniques based on the bootstrap principle that allow sources of error and bias to be simulated and propagated into assay results. We demonstrate how deceptively simple operations--such as the creation of a dilution series with a robotic liquid handler--can significantly amplify imprecision and even contribute substantially to bias. To illustrate these techniques, we review an example of how the choice of dispensing technology can impact assay measurements, and show how large contributions to discrepancies between assays can be easily understood and potentially corrected for. These simple modeling techniques--illustrated with an accompanying IPython notebook--can allow modelers to understand the expected error and bias in experimental datasets, and even help experimentalists design assays to more effectively reach accuracy and imprecision goals.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Beyond accuracy, precision and TAE: Direct assay validation against product specification aligned with USP
Davor Josipovic·The AAPS JournalPeer-reviewed·Aug 19, 2025
- What Could Go Wrong? Promoting Success by Planning for Failure in Label-Free Biosensor Assay Development
Sajida Chowdhury, Samantha M. Grist, … Karen C. Cheung·Biosensors and Bioelectronics XPeer-reviewed·Feb 16, 2026
- Theoretical expectations versus empirical observations in the bacterial enumeration process using serial dilution
Monika Jain, Shuhada Begum, … Suvendra Kumar Ray·bioRxiv·Nov 28, 2024
- In silico modelling demonstrates that user variability during tumour measurement can affect in vivo therapeutic efficacy outcomes
Jake Murkin, Hope E. Amos, … Karl Turley·bioRxiv·Apr 20, 2022
- Violating the normality assumption may be the lesser of two evils
U. Knief, W. Forstmeier·bioRxiv·May 5, 2020
- Understanding the mismatch between in-vivo and in-silico rhinomanometry
Marco Atzori, Gabriele Dini Ciacci, Maurizio Quadrio·Medical & Biological Engineering & ComputingPeer-reviewed·Sep 25, 2025